VTRS
HEALTHCAREViatris Inc
$15.95+0.43 (+2.77%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving VTRS Today?
No stock-specific AI insight has been generated for VTRS yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$7.90$17.45
$15.95
Fundamentals
Market Cap$18.1B
P/E Ratio—
EPS$-3.00
Dividend Yield0.03%
Dividend / Share$0.48
ROE-0.2%
Profit Margin-0.2%
Debt / Equity—
Trading
Volume22.5M
Avg Volume (10D)—
Shares Outstanding1.16B
VTRS News
24 articles- TBPH Q1 Earnings Beat Amid Strategic Restructuring & Pipeline HurdleYahoo Finance·May 8, 2026
- Viatris Inc. Q1 2026 Earnings Call SummaryMoby·May 8, 2026
- Assessing Viatris (VTRS) Valuation After Its Recent Share Price ReboundYahoo Finance·May 8, 2026
- Viatris to Present at the Bank of America Securities 2026 Healthcare ConferenceYahoo Finance·May 7, 2026
- Viatris (VTRS) Q1 2026 Earnings TranscriptMotley Fool·May 7, 2026
- Viatris Q1 EPS Beats Estimates, Revenues up 8% Driven by Greater ChinaZacks Investment Research·May 7, 2026
- Here's What Key Metrics Tell Us About Viatris (VTRS) Q1 EarningsYahoo Finance·May 7, 2026
- Viatris (VTRS) Q1 Earnings and Revenues Surpass EstimatesYahoo Finance·May 7, 2026
- Earnings Flash (VTRS) Viatris Inc. Reports Q1 Revenue $3.52B, vs. FactSet Est of $3.36Bwww.marketscreener.com·May 7, 2026
- Viatris’s (NASDAQ:VTRS) Q1 CY2026: Beats On RevenueYahoo Finance·May 7, 2026
- Viatris Reports First-Quarter 2026 Financial ResultsYahoo Finance·May 7, 2026
- Exploring Analyst Estimates for Viatris (VTRS) Q1 Earnings, Beyond Revenue and EPSYahoo Finance·May 6, 2026
- Are Wall Street Analysts Bullish on Viatris Stock?Barchart·May 6, 2026
- Viatris Gears Up to Report Q1 Earnings: What's in the Cards?Yahoo Finance·May 5, 2026
- Viatris Announces Quarterly DividendYahoo Finance·May 5, 2026
- Edwards names Theodora Mistras as CFOMedtechdive·May 5, 2026
- Edwards Lifesciences Announces Appointment of CFOYahoo Finance·May 4, 2026
- Viatris Announces Chief Financial Officer TransitionYahoo Finance·May 4, 2026
- Is It Too Late To Consider Viatris (VTRS) After Its Strong One Year Share Price RunYahoo Finance·May 3, 2026
- Chlorpheniramine Maleate - Global Market Insights, Competitive Landscape & Industry Forecast to 2033 Featuring Viatris, Alkem Labs, Merck & Co., Johnson & Johnson, Capellon Pharma and MoreYahoo Finance·May 1, 2026
- Viatris Announces Several Data Presentations on Investigational Low-Dose Estrogen Combined Hormonal Contraceptive Weekly Patch at the 2026 American College of Obstetricians and Gynecologists Annual Clinical & Scientific MeetingYahoo Finance·May 1, 2026
- Opus Genetics Announces Data Presentations at the 2026 American Society of Cataract and Refractive Surgery Annual MeetingGlobeNewswire Inc.·Apr 10, 2026
- Viatris at $14: A Double-Digit FCF Yield Hiding in Plain SightInvesting.com·Apr 2, 2026
- Systemic Lupus Erythematosus Clinical Trial Pipeline Accelerates as 120+ Pharma Companies Rigorously Developing Drugs for Market Entry | DelveInsightGlobeNewswire Inc.·Apr 1, 2026
All 24 articles loaded
Price Data
Open$14.95
Previous Close$15.52
Day High$15.08
Day Low$14.78
52 Week High$17.45
52 Week Low$7.90
52-Week Range
$7.90$17.45
$15.95
Fundamentals
Market Cap$18.1B
P/E Ratio—
EPS$-3.00
Dividend Yield0.03%
Dividend / Share$0.48
ROE-0.2%
Profit Margin-0.2%
Debt / Equity—
Trading
Volume22.5M
Avg Volume (10D)—
Shares Outstanding1.16B
About Viatris Inc
Viatris Inc. is an American global healthcare company headquartered in Canonsburg, Pennsylvania.
HEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICDRUG MANUFACTURERS - SPECIALTY & GENERIC
CIK—
Composite FIGI—
Share Class FIGI—